Use of biologic grafts in pelvic organ prolapse surgery
Use of biologic grafts in pelvic organ prolapse surgeryPelvic organ prolapse is a very prevalent condition, affecting up to half of all women over 50 years old. Biological grafts may be useful in certain patients but long-term trials are needed to guide their proper use.
Female urology research examines sling surgery, robotic approaches, meshSling surgery, robotic approaches to sacrocolpopexy and pelvic organ prolapse, and mesh are among the key studies in the area of female urology to watch for at the 2014 AUA annual meeting.
New lightweight mesh launched for sacrocolpopexyCaldera Medical has announced FDA clearance and the launch of Vertessa Lite, which Caldera calls a supple, lightweight, yet strong polypropylene mesh for use in abdominal sacrocolpopexy procedures for vaginal vault prolapse.
Pelvic organ prolapse surgery less effective than expectedResearchers found that nearly one-third of women experienced a recurrence of POP, either on examination or by reported symptoms, within 5 years of surgery.
Sacrocolpopexy success rates decline over timeInitial success rates of abdominal sacrocolpopexy for pelvic organ prolapse decline over the long term, according to a recently published multicenter study.
AUGS issues guide on sacrocolpopexy credentialingThe American Urogynecologic Society (AUGS) has released new guidelines for privileging and credentialing physicians for sacrocolpopexy in an effort to assist health care institutions when considering granting privileges to perform the procedure for pelvic organ prolapse (POP).